Previous Tx in Metastatic Melanoma May Cut Response to ACT TIL
Prior therapy linked to lower objective response rate to adoptive cell transfer with tumor-infiltrating lymphocytes compared with no prior therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.